Antimicrobial activities of heparin-binding peptides

被引:153
|
作者
Andersson, E
Rydengård, V
Sonesson, A
Mörgelin, M
Björck, L
Schmidtchen, A
机构
[1] Lund Univ, Biomed Ctr, Dept Med Microbiol Dermatol & Infect, Dermatol Sect, S-22100 Lund, Sweden
[2] Lund Univ, Biomed Ctr, Dept Cell & Mol Biol, Sect Mol Pathogenesis, S-22100 Lund, Sweden
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 06期
关键词
antimicrobial; cathelicidin; defensin; heparin binding; glycosaminoglycan;
D O I
10.1111/j.1432-1033.2004.04035.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antimicrobial peptides are effector molecules of the innate immune system. We recently showed that the human antimicrobial peptides alpha-defensin and LL-37 bind to glycosaminoglycans (heparin and dermatan sulphate). Here we demonstrate the obverse, i.e. structural motifs associated with heparin affinity (cationicity, amphipaticity, and consensus regions) may confer antimicrobial properties to a given peptide. Thus, heparin-binding peptides derived from laminin isoforms, von Willebrand factor, vitronectin, protein C inhibitor, and fibronectin, exerted antimicrobial activities against Gram-positive and Gram-negative bacteria. Similar results were obtained using heparin-binding peptides derived from complement factor C3 as well as consensus sequences for heparin-binding (Cardin and Weintraub motifs). These sequence motifs, and additional peptides, also killed the fungus Candida albicans. These data will have implications for the search for novel antimicrobial peptides and utilization of heparin-protein interactions should be helpful in the identification and purification of novel antimicrobial peptides from complex biological mixtures. Finally, consensus regions may serve as templates for de novo synthesis of novel antimicrobial molecules.
引用
收藏
页码:1219 / 1226
页数:8
相关论文
共 50 条
  • [31] GLYCOSAMINOGLYCAN SPECIFICITY OF A HEPARIN-BINDING PEPTIDE
    TAYLOR, GJ
    YORKE, SC
    HARDING, DRK
    PEPTIDE RESEARCH, 1995, 8 (05): : 286 - 293
  • [32] Heparin-binding proteins in the rat brain
    Belousova, TV
    Ushakova, GA
    NEUROPHYSIOLOGY, 2001, 33 (06) : 339 - 343
  • [33] DEFINING THE HEPARIN-BINDING DOMAIN OF ANTITHROMBIN
    WU, YI
    SHEFFIELD, WP
    BLAJCHMAN, MA
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (01) : 83 - 95
  • [34] Promoting angiogenesis with heparin-binding nanostructures
    Han, Xiaoqiang
    Lomasney, Jon
    Rajangam, Kanya
    Stupp, Samuel
    CIRCULATION, 2006, 114 (18) : 80 - 81
  • [35] HEPARIN-BINDING PROPERTIES OF LACTOFERRIN AND LYSOZYME
    ZOU, S
    MAGURA, CE
    HURLEY, WL
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1992, 103 (04): : 889 - 895
  • [36] Heparin-binding domains in vascular biology
    Muñoz, EM
    Linhardt, RJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (09) : 1549 - 1557
  • [37] The design and evaluation of heparin-binding foldamers
    Choi, S
    Clements, DJ
    Pophristic, V
    Ivanov, I
    Vemparala, S
    Bennett, JS
    Klein, ML
    Winkler, JD
    DeGrado, WE
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (41) : 6685 - 6689
  • [38] CHARACTERIZATION OF THE HEPARIN-BINDING EXOSITE OF THROMBIN
    GAN, ZR
    LI, YP
    LEWIS, SD
    SHAFER, JA
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1044 - 1044
  • [39] Heparin-Binding Proteins in the Rat Brain
    T. V. Belousova
    G. A. Ushakova
    Neurophysiology, 2001, 33 : 339 - 343
  • [40] A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities
    Liu, SC
    Zhou, FY
    Hook, M
    Carson, DD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1739 - 1744